688271 联影医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入8,858,91627.39%10,300,10411,410,7669,238,1237,253,756
减:营业总成本7,918,57219.83%9,385,2729,857,9467,774,1816,004,198
    其中:营业成本4,693,77728.60%5,300,1626,039,1594,769,9983,668,599
               财务费用(43,823)-28.05%(112,290)(148,887)(98,725)(24,430)
               资产减值损失480-99.05%13,843(42,886)(74,747)(25,198)
公允价值变动收益(41,816)-6,688.17%37,000(6,063)28,500(10,588)
投资收益60,685-15.99%98,074110,34512,66762,250
    其中:对联营企业和合营企业的投资收益1,819-119.96%(5,623)(15,872)(7,651)(3,055)
营业利润1,181,12664.69%1,366,3562,141,5151,928,2431,696,132
利润总额1,178,55365.56%1,351,7082,142,2551,919,7951,697,543
减:所得税费用76,24742.60%109,784164,500269,710294,033
净利润1,102,30667.42%1,241,9241,977,7551,650,0861,403,509
减:非控股权益(17,928)40.35%(19,945)3,462(5,998)(13,675)
股东净利润1,120,23466.91%1,261,8691,974,2921,656,0841,417,185

市场价值指针
每股收益 (元) *1.36065.85%1.5402.4002.1901.960
每股派息 (元) *0.1308.33%0.2000.2500.201--
每股净资产 (元) *25.2488.24%24.15022.89221.2146.960
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容